» Articles » PMID: 17761230

Acceptability of Sodium-reduced Research Diets, Including the Dietary Approaches To Stop Hypertension Diet, Among Adults with Prehypertension and Stage 1 Hypertension

Overview
Journal J Am Diet Assoc
Publisher Elsevier
Date 2007 Sep 1
PMID 17761230
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Examine the acceptability of sodium-reduced research diets.

Design: Randomized crossover trial of three sodium levels for 30 days each among participants randomly assigned to one of two dietary patterns.

Participants/setting: Three hundred fifty-four adults with prehypertension or stage 1 hypertension who were participants in the Dietary Approaches to Stop Hypertension (DASH-Sodium) outpatient feeding trial.

Intervention: Participants received their assigned diet (control or DASH, rich in fruits, vegetables, and low-fat dairy products), each at three levels of sodium (higher, intermediate, and lower) corresponding to 3,500, 2,300, and 1,200 mg/day (150, 100, and 50 mmol/day) per 2,100 kcal.

Main Outcome Measures: Nine-item questionnaire on liking and willingness to continue the assigned diet and its level of saltiness using a nine-point scale, ranging from one to nine.

Statistical Analyses Performed: Generalized estimating equations to test participant ratings as a function of sodium level and diet while adjusting for site, feeding cohort, carryover effects, and ratings during run-in.

Results: Overall, participants rated the saltiness of the intermediate level sodium as most acceptable (DASH group: 5.5 for intermediate vs 4.5 and 4.4 for higher and lower sodium; control group: 5.7 for intermediate vs 4.9 and 4.7 for higher and lower sodium) and rated liking and willing to continue the DASH diet more than the control diet by about one point (ratings range from 5.6 to 6.6 for DASH diet and 5.2 to 6.1 for control diet). Small race differences were observed in sodium and diet acceptability.

Conclusions: Both the intermediate and lower sodium levels of each diet are at least as acceptable as the higher sodium level in persons with or at risk for hypertension.

Citing Articles

Economic and Cultural Assessment of the DASH Eating Plan for Low-Income African Americans: An Integrative Review.

White B, OoNorasak K, Sesay N, Haskins D, Robinson C Int J Environ Res Public Health. 2024; 21(11).

PMID: 39595747 PMC: 11594161. DOI: 10.3390/ijerph21111480.


Feasibility of Low-Sodium, High-Potassium Processed Foods and Their Effect on Blood Pressure in Free-Living Japanese Men: A Randomized, Double-Blind Controlled Trial.

Umeki Y, Hayabuchi H, Adachi H, Ohta M Nutrients. 2021; 13(10).

PMID: 34684498 PMC: 8540744. DOI: 10.3390/nu13103497.


The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study.

Rai S, Fung T, Lu N, Keller S, Curhan G, Choi H BMJ. 2017; 357:j1794.

PMID: 28487277 PMC: 5423545. DOI: 10.1136/bmj.j1794.


Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.

Juraschek S, Gelber A, Choi H, Appel L, Miller 3rd E Arthritis Rheumatol. 2016; 68(12):3002-3009.

PMID: 27523583 PMC: 5363397. DOI: 10.1002/art.39813.


Salt reduction and hypertension in China: a concise state-of-the-art review.

Liu Y, Li H, Hong S, Yin X Cardiovasc Diagn Ther. 2015; 5(3):191-6.

PMID: 26090330 PMC: 4451313. DOI: 10.3978/j.issn.2223-3652.2015.05.01.


References
1.
Svetkey L, Sacks F, Obarzanek E, Vollmer W, Appel L, Lin P . The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc. 1999; 99(8 Suppl):S96-104. DOI: 10.1016/s0002-8223(99)00423-x. View

2.
Campbell M, Demark-Wahnefried W, Symons M, Kalsbeek W, Dodds J, Cowan A . Fruit and vegetable consumption and prevention of cancer: the Black Churches United for Better Health project. Am J Public Health. 1999; 89(9):1390-6. PMC: 1508774. DOI: 10.2105/ajph.89.9.1390. View

3.
Kumanyika S, Cook N, Cutler J, Belden L, Brewer A, Cohen J . Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens. 2004; 19(1):33-45. DOI: 10.1038/sj.jhh.1001774. View

4.
Lichtenstein A, Appel L, Brands M, Carnethon M, Daniels S, Franch H . Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006; 114(1):82-96. DOI: 10.1161/CIRCULATIONAHA.106.176158. View

5.
Appel L . Salt reduction in the United States. BMJ. 2006; 333(7568):561-2. PMC: 1569959. DOI: 10.1136/bmj.38971.635799.AB. View